Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion type Assertion NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_head.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion description "[Based on methylation in primary tumors compared to normal adjacent tissues, NKX2-5, CLSTN1, SPOCK2, SLC16A12, DPYS and NSE1 are candidate biomarkers for prostate cancer (methylation range 50%-85%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion evidence source_evidence_literature NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion SIO_000772 18446232 NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion wasDerivedFrom befree-2016 NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion wasGeneratedBy ECO_0000203 NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.